Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2273 of 5804
-
CF breakthrough may lower antibiotic doses, reduce side effects
Knowledge-focused Recruiting nowCystic fibrosis (CF) is associated with major pharmacokinetic and pharmacodynamic alterations affecting antibiotic exposure, including changes in absorption, distribution, metabolism, and elimination. Historically, these alterations justified the use of higher antibiotic doses in…
Sponsor: Fondation Ildys • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New drug CLIO-8221 takes on advanced solid tumors in early trial
Disease control Recruiting nowThe study will be conducted in 2 phases: Phase 1: Dose-escalation and Dose Level Expansion, Phase 1 will determine the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE). Phase 2: Tumor-Specific Expansions with Dose Optimization, Phase 2 will further evaluat…
Phase: PHASE1, PHASE2 • Sponsor: Callio Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can clever ads stop young women from drinking and prevent breast cancer?
Prevention Recruiting nowThis randomized trial aims to test the effects of co-created breast cancer counter marketing intervention messages for reducing alcohol consumption and impacting awareness and beliefs about the breast cancer risks from alcohol consumption in young adult women.
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New Eye-Tracker gives voice to ventilated ICU patients
Symptom relief Recruiting nowIntensive care is a unit that admits ventilated patients. Hospitalization is extremely challenging for these patients. Their vital prognosis is at stake, and they often have difficulty moving due to pain, edema, neuromyopathy, or the presence of monitoring cables. They are also h…
Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New dissolving nasal dressing could improve sinus surgery recovery
Disease control ENROLLING_BY_INVITATIONThe primary objective of the study is to evaluate the safety and effectiveness of OCEAN as an adjunct aid in wound healing after nasal/sinus surgery and to demonstrate that OCEAN is non-inferior compared to a steroid-eluting sinus stent.
Phase: NA • Sponsor: Polyganics BV • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI could revolutionize dementia diagnosis
Knowledge-focused Recruiting nowDementia affects millions of people worldwide, and early diagnosis is essential for getting the right care and support. Doctors rely on collateral histories (accounts from family members or caregivers) to understand changes in a person's memory and thinking. However, these histor…
Sponsor: Northumbria Healthcare NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Stem cell trial aims to regrow lungs in COPD patients
Disease control Recruiting nowChronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide with the characterization of obstructed airflow. In a large number of patients, diffusion function is impaired along with the progression of disease. REGEND007 cell therapy, comprised of ai…
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New antibody cocktail aims to block HIV without daily pills
Disease control Recruiting nowThis study is testing a lab-made antibody called ePGT121v1-LS that targets a specific part of HIV. Researchers will give it by vein (IV) and under the skin (SC), both on its own and together with two other antibodies, VRC07-523LS and PGDM1400LS, which target different parts of th…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New shot could tame seasonal sniffles for good?
Symptom relief Recruiting nowThis study is a multicenter, open-label, Phase II, single-arm clinical trial, with a planned enrollment of 200 to 300 subjects. Its primary objective is to evaluate the safety and efficacy of TQH2722 injection in the treatment of seasonal allergic rhinitis.
Phase: PHASE2 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could a simple ear rinse ease fibromyalgia pain?
Symptom relief Recruiting nowFibromyalgia is the most common centralized pain disorder, affecting up to 3% of the population. Current treatments are incompletely effective, often poorly tolerated, and costly: there remains an urgent need for novel, effective, and well-tolerated therapy. Preliminary data sugg…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
AI takes on doctors in diagnostic showdown
Diagnosis Recruiting nowThis study evaluates the diagnostic performance of a multimodal artificial intelligence (AI) system (AIMD.1) using de-identified medical images and semi-synthetic patient simulations. The study combines retrospective analysis of existing publicly available image datasets with pro…
Sponsor: Magic Health Inc. (d.b.a. Nolla Health) • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New scoring system aims to help osteoporosis patients walk again faster after spine fractures
Knowledge-focused Recruiting nowThis is an international multicenter prospective observational study. Patients with radiologically confirmed, symptomatic, single- or multilevel contiguous TL (from T1 to L5) fractures as a result of primary osteoporosis will be recruited from participating clinics/hospitals (ie,…
Sponsor: AO Foundation, AO Spine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can VR games heal the fog after ICU delirium?
Symptom relief Recruiting nowThe purpose of this study is to measure the feasibility, acceptability of virtual reality (VR) brain games and estimate their effect on memory, attention, and mood for ICU survivors. The VR program will be used at home through a headset and hand controls.
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New drug MG2512 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis is an open-label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and efficacy of MG2512 injection in participants with advanced solid tumors.
Phase: PHASE1 • Sponsor: Shanghai Mabgen Biopharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a Dairy-Free shake help kids with EoE feel better?
Disease control Recruiting nowThis study aims to introduce a new dietary therapy for Eosinophilic Esophagitis (EoE) patients by using partial enteral nutrition (PEN) to enhance remission rates and explore how this approach affects immune function, gut microbiota, and environmental toxin exposures.
Phase: NA • Sponsor: Kate Farms Inc • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New eye drop combo aims to lower pressure in glaucoma patients
Disease control OngoingFirecrest study is evaluating the intraocular pressure (IOP)-lowering effect, safety, and tolerability of Qlaris' preservative free \[PF\], fixed-dose combination \[FDC\] investigational product (IP) in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Phase: PHASE2, PHASE3 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Brittle bone kids: is romosozumab safe Long-Term?
Disease control Recruiting nowThe primary objective of this trial is to evaluate the safety of romosozumab in participants with osteogenesis imperfecta (OI) that have completed Study 20200105, regardless of whether they received investigational product (romosozumab) until the last protocol-specified dose or e…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New pill could ease pain after hip surgery without opioids
Symptom relief Recruiting nowThis is a phase IIa, multicenter ,randomized, double-blind, Double-Dummy, Active- and placebo-controlled study designed to evaluate the efficacy, safety and kinetic characteristics of TRD205 tablets for postoperative analgesia after unilateral hip arthroplasty
Phase: PHASE2 • Sponsor: Beijing Tide Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Shock waves could be new weapon against knee pain
Symptom relief Recruiting nowThis study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) versus structured therapeutic exercise in patients with chronic knee osteoarthritis (KOA), with respect to pain reduction and improvement of knee function.
Phase: NA • Sponsor: German International University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Gene study aims to personalize lung cancer drug therapy
Knowledge-focused OngoingExplore the relationship between drug target ALK gene single nucleotide polymorphisms and ALECENSA - Alectinib therapeutic-effects in patients with non-small cell lung cancer, based on Oxford precisely sequencing drug targets' genes. Explore the relationship between drug target …
Phase: PHASE2, PHASE3 • Sponsor: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC